Oncocyte To Announce Third Quarter 2024 Financial Results on Nov. 12
Oncocyte Corp (Nasdaq: OCX) has announced it will release its third quarter 2024 financial results on Tuesday, November 12, 2024, after U.S. market closes. The company will host a conference call and webcast at 2:00 p.m. Pacific Time / 5:00 p.m. Eastern Time on the same day. Investors can access the call via toll-free number 800-715-9871 for domestic callers or +1 (646) 307-1963 for international callers, using Conference ID 4153469. A webcast replay will be available on the company's website after the call.
Oncocyte Corp (Nasdaq: OCX) ha annunciato che pubblicherà i suoi risultati finanziari del terzo trimestre 2024 martedì 12 novembre 2024, dopo la chiusura del mercato statunitense. L'azienda ospiterà una teleconferenza e un webcast alle 14:00 ora del Pacifico / 17:00 ora dell'Est nello stesso giorno. Gli investitori possono accedere alla chiamata tramite il numero verde 800-715-9871 per i chiamanti domestici o +1 (646) 307-1963 per i chiamanti internazionali, utilizzando l'ID conferenza 4153469. Una registrazione del webcast sarà disponibile sul sito web dell'azienda dopo la chiamata.
Oncocyte Corp (Nasdaq: OCX) ha anunciado que publicará sus resultados financieros del tercer trimestre de 2024 el martes 12 de noviembre de 2024, después del cierre del mercado estadounidense. La compañía llevará a cabo una conferencia telefónica y un webcast a las 2:00 p.m. hora del Pacífico / 5:00 p.m. hora del Este el mismo día. Los inversores pueden acceder a la llamada a través del número gratuito 800-715-9871 para los que llaman desde Estados Unidos o +1 (646) 307-1963 para los que llaman desde otros países, utilizando el ID de la conferencia 4153469. Una grabación del webcast estará disponible en el sitio web de la empresa después de la llamada.
온코사이트 코퍼레이션 (Nasdaq: OCX)는 2024년 3분기 재무 결과를 2024년 11월 12일 화요일, 미국 시장이 마감한 후 발표한다고 발표했습니다. 회사는 동일한 날 태평양 표준시로 오후 2시 / 동부 표준시로 오후 5시에 전화 회의 및 웹캐스트를 개최합니다. 투자자들은 국내 통화자에게는 무료 전화번호 800-715-9871을, 국제 통화자에게는 +1 (646) 307-1963을 이용하여, 회의 ID 4153469를 통해 전화를 이용할 수 있습니다. 웹캐스트 재생은 전화 회의 후 회사 웹사이트에서 이용 가능합니다.
Oncocyte Corp (Nasdaq: OCX) a annoncé qu'elle publiera ses résultats financiers du troisième trimestre 2024 le mardi 12 novembre 2024, après la fermeture des marchés américains. La société organisera une conférence téléphonique et un webcast le même jour à 14h00 heure du Pacifique / 17h00 heure de l'Est. Les investisseurs peuvent accéder à l'appel via le numéro gratuit 800-715-9871 pour les appelants nationaux ou au +1 (646) 307-1963 pour les appelants internationaux, en utilisant l'ID de conférence 4153469. Un enregistrement du webcast sera disponible sur le site Web de la société après l'appel.
Oncocyte Corp (Nasdaq: OCX) hat angekündigt, dass es am Dienstag, den 12. November 2024, nach dem US-Marktabschluss seine Finanzergebnisse für das dritte Quartal 2024 veröffentlichen wird. Das Unternehmen wird am selben Tag um 14:00 Uhr Pazifischer Zeit / 17:00 Uhr Eastern Time eine Telefonkonferenz und ein Webcast ausrichten. Investoren können über die gebührenfreie Nummer 800-715-9871 für Anrufer aus dem Inland oder +1 (646) 307-1963 für internationale Anrufer auf die Konferenz zugreifen, indem sie die Konferenz-ID 4153469 verwenden. Eine Aufzeichnung des Webcasts wird nach der Konferenz auf der Website des Unternehmens verfügbar sein.
- None.
- None.
Conference Call and Webcast on Tuesday, November 12, 2024, at 2:00 p.m. PT / 5:00 p.m. ET
IRVINE, Calif., Nov. 06, 2024 (GLOBE NEWSWIRE) -- Oncocyte Corp. (Nasdaq: OCX), a diagnostics technology company, announced today that the company will release its third quarter 2024 financial results on Tuesday, November 12, 2024, after U.S. market closes. The company will also host a conference call and webcast on Tuesday, November 12, 2024, at 2:00 p.m. Pacific Time / 5:00 p.m. Eastern Time to discuss its financial results and highlights.
Interested parties may access the live call via telephone by dialing toll free 800-715-9871 for domestic callers. Once dialed in, ask to be joined to the Oncocyte Corporation call.
The live webcast of the call may be accessed by visiting the “Events & Presentations” section of the Company’s website at https://investors.oncocyte.com. A replay of the webcast will be available on the Company’s website shortly after the conclusion of the call.
CONFERENCE CALL DETAILS:
Participant Toll-Free Dial-In Number: (800) 715-9871
Participant Toll Dial-In Number: +1 (646) 307-1963
Conference ID: 4153469
WEBCAST DETAILS: https://events.q4inc.com/attendee/686764682
About Oncocyte
Oncocyte is a diagnostics technology company. The Company’s tests are designed to help provide clarity and confidence to physicians and their patients. VitaGraft™ is a clinical blood-based solid organ transplantation monitoring test. GraftAssure™ is a research use only (RUO) blood-based solid organ transplantation monitoring test. DetermaIO™ is a gene expression test that assesses the tumor microenvironment to predict response to immunotherapies. DetermaCNI™ is a blood-based monitoring tool for monitoring therapeutic efficacy in cancer patients. For more information about Oncocyte, please visit https://oncocyte.com/.
For more information about our products, please visit the following web pages:
VitaGraft Kidney™ - https://oncocyte.com/vitagraft-kidney/
VitaGraft Liver™ - https://oncocyte.com/vitagraft-liver/
GraftAssure™ - https://oncocyte.com/graftassure/
DetermaIO™ - https://oncocyte.com/determa-io/
DetermaCNI™ - https://oncocyte.com/determa-cni/
VitaGraft™, GraftAssure™, DetermaIO™, and DetermaCNI™ are trademarks of Oncocyte Corporation.
CONTACT:
Jeff Ramson
PCG Advisory
(646) 863-6893
jramson@pcgadvisory.com
FAQ
When will Oncocyte (OCX) release Q3 2024 earnings?
What time is Oncocyte's (OCX) Q3 2024 earnings call?
How can I join Oncocyte's (OCX) Q3 2024 earnings call?
